Federal Judge Blocks Trump NIH Grant Cuts Tied to Diversity Research

A federal judge in Massachusetts has invalidated a series of Trump administration orders that wiped out hundreds of research grants from the National Institutes of Health. The cuts targeted studies touching on diversity, gender identity, and vaccine hesitancy—topics the administration deemed ideologically driven rather than scientifically sound.

Judge William Young, who has served on the U.S. District Court since his 1985 appointment by President Reagan, concluded after a trial Monday that the directives were arbitrary and capricious, lacking the reasoned analysis that federal law requires when agencies alter their policies. The ruling came in response to lawsuits filed by a coalition of public health organizations and by Democratic state attorneys general. Young's order vacated the challenged directives and instructed the Trump administration to comply promptly, though the full written opinion had not yet been published as of Tuesday.

The speed with which the cuts were implemented became a central point of contention. NIH Acting Director Dr. Matthew Memoli spent only minutes reviewing and deciding which grants and funding opportunities would be terminated. Opponents of the cuts argued in court filings that such lightning-speed implementation could not possibly reflect the kind of careful deliberation the law demands. They also pointed out that the administration never clearly defined what actually qualified as banned "DEI studies," making it impossible for researchers to understand which work fell under the prohibition. During the trial, Young expressed strong criticism of the process, telling the courtroom he had "never seen a record where racial discrimination was so palpable" and said he would "be blind not to call it out."

Dr. Peter Lurie, head of the Center for Science in the Public Interest and one of the groups that brought the lawsuit, called the ruling a vindication. The ideologically motivated directives, he said in a statement, had been found unlawful. The Massachusetts attorney general's office noted that the ruling halted the cancellation of millions of dollars in grants that had already been awarded and would allow funding for medical research to continue.

The Trump administration is not backing down. Andrew Nixon, communications director for the Department of Health and Human Services, said the department is "exploring all legal options, including filing an appeal and moving to stay the order." The department maintains that it was right to end funding for research that prioritized what it calls ideological agendas over scientific rigor, and that taxpayer dollars should support what it describes as "gold standard science" rather than "divisive DEI mandates or gender ideology."

This ruling is one piece of a larger legal battle over the administration's research funding cuts. Other federal cases are underway challenging additional terminations, including cuts that have disrupted studies at universities like Harvard and Columbia focused on cancer and other diseases. Another federal judge in Massachusetts already blocked the NIH from implementing a separate policy change that would have cut funding for research overhead costs—a decision the Trump administration is appealing. The legal landscape remains unsettled, with multiple courts weighing in on different aspects of the administration's effort to reshape how federal research dollars are allocated.